PolyPid wins FDA designation for antibiotic drug reservoir

Pharmaceutical company PolyPid said today that its D-Plex antibiotic drug reservoir won Qualified Infectious Disease Product status from the FDA.

Under the designation, the Israel-based company’s product will be eligible for priority review, fast-track status and an additional 5 years of market exclusivity.

Get the full story at our sister site, Drug Delivery Business News.

The post PolyPid wins FDA designation for antibiotic drug reservoir appeared first on MassDevice.

from MassDevice http://ift.tt/2n7k9VF